Literature DB >> 19531389

Diverse recognition of conserved orthopoxvirus CD8+ T cell epitopes in vaccinated rhesus macaques.

Stephen R Walsh1, Jacqueline Gillis, Björn Peters, Bianca R Mothé, John Sidney, Alessandro Sette, R Paul Johnson.   

Abstract

Vaccinia virus (VACV) induces a vigorous virus-specific CD8+ T cell response that plays an important role in control of poxvirus infection. To identify immunodominant poxvirus proteins and to facilitate future testing of smallpox vaccines in non-human primates, we used an algorithm for the prediction of VACV peptides able to bind to the common macaque MHC class I molecule Mamu-A*01. We synthesized 294 peptides derived from 97 VACV ORFs; 100 of these peptides did not contain the canonical proline at position three of the Mamu-A*01 binding motif. Cellular immune responses in PBMC from two vaccinia-vaccinated Mamu-A*01+ macaques were assessed by IFNgamma ELISPOT assays. Vaccinated macaques recognized 17 peptides from 16 different ORFs with 6 peptides recognized by both macaques. Comparison with other orthopoxvirus sequences revealed that 12 of these epitopes are strictly conserved between VACV, variola, and monkeypoxvirus. ELISPOT responses were also observed to eight epitopes that did not contain the canonical P3 proline. These results suggest that the virus-specific CD8+ T cell response is broadly directed against multiple VACV proteins and that a subset of these T cell epitopes is highly conserved among orthopoxviruses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19531389      PMCID: PMC2765250          DOI: 10.1016/j.vaccine.2009.05.077

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  82 in total

1.  High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL.

Authors:  M Derby; M Alexander-Miller; R Tse; J Berzofsky
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

2.  HLA-A2-restricted human CD8(+) cytotoxic T lymphocyte responses to a novel epitope in vaccinia virus that is conserved among orthopox viruses.

Authors:  Yuzhi Dong; Thomas N Denny
Journal:  J Infect Dis       Date:  2006-06-12       Impact factor: 5.226

3.  Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination.

Authors:  Francis A Ennis; John Cruz; Walter E Demkowicz; Alan L Rothman; David J McClain
Journal:  J Infect Dis       Date:  2002-05-17       Impact factor: 5.226

4.  The Vaccinia virus E8R gene product: a viral membrane protein that is made early in infection and packaged into the virions' core.

Authors:  Laura Doglio; Ario De Marco; Sibylle Schleich; Norbert Roos; Jacomine Krijnse Locker
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

5.  Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses.

Authors:  James T Snyder; Igor M Belyakov; Amiran Dzutsev; François Lemonnier; Jay A Berzofsky
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

6.  Identification of MHC class I sequences in Chinese-origin rhesus macaques.

Authors:  Julie A Karl; Roger W Wiseman; Kevin J Campbell; Alex J Blasky; Austin L Hughes; Betsy Ferguson; Daniel S Read; David H O'Connor
Journal:  Immunogenetics       Date:  2007-12-21       Impact factor: 2.846

7.  Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.

Authors:  Ingo Drexler; Caroline Staib; Wolfgang Kastenmuller; Stefan Stevanović; Burkhard Schmidt; François A Lemonnier; Hans-Georg Rammensee; Dirk H Busch; Helga Bernhard; Volker Erfle; Gerd Sutter
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-23       Impact factor: 11.205

8.  MHC class I alleles influence set-point viral load and survival time in simian immunodeficiency virus-infected rhesus monkeys.

Authors:  Thorsten Mühl; Michael Krawczak; Peter Ten Haaft; Gerhard Hunsmann; Ulrike Sauermann
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

9.  A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection.

Authors:  Erika Assarsson; John Sidney; Carla Oseroff; Valerie Pasquetto; Huynh-Hoa Bui; Nicole Frahm; Christian Brander; Bjoern Peters; Howard Grey; Alessandro Sette
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

10.  Quantitation of CD8+ T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses.

Authors:  Masanori Terajima; John Cruz; Gregory Raines; Elizabeth D Kilpatrick; Jeffrey S Kennedy; Alan L Rothman; Francis A Ennis
Journal:  J Exp Med       Date:  2003-03-31       Impact factor: 14.307

View more
  15 in total

1.  Identification of the peptide-binding motif recognized by the pigtail macaque class I MHC molecule Mane-A1*082:01 (Mane A*0301).

Authors:  Carrie Moore; John Sidney; A Michelle English; Amanda Wriston; Donald F Hunt; Jeffrey Shabanowitz; Scott Southwood; Kate Bradley; Bernard A P Lafont; Bianca R Mothé; Alessandro Sette
Journal:  Immunogenetics       Date:  2012-01-26       Impact factor: 2.846

2.  Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administration.

Authors:  Marissa B Wilck; Michael S Seaman; Lindsey R Baden; Stephen R Walsh; Lauren E Grandpre; Colleen Devoy; Ayush Giri; Jane A Kleinjan; Lizanne C Noble; Kristen E Stevenson; Haesook T Kim; Raphael Dolin
Journal:  J Infect Dis       Date:  2010-05-01       Impact factor: 5.226

Review 3.  Epitope prediction and identification- adaptive T cell responses in humans.

Authors:  John Sidney; Bjoern Peters; Alessandro Sette
Journal:  Semin Immunol       Date:  2020-10-31       Impact factor: 11.130

Review 4.  Smallpox vaccines: targets of protective immunity.

Authors:  Bernard Moss
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

5.  A broadly applicable approach to T cell epitope identification: application to improving tumor associated epitopes and identifying epitopes in complex pathogens.

Authors:  Michael D Valentino; C Siddiq Abdul-Alim; Zachary J Maben; Denise Skrombolas; Lucinda L Hensley; Thomas H Kawula; Michelle Dziejman; Edith M Lord; Jeffrey A Frelinger; John G Frelinger
Journal:  J Immunol Methods       Date:  2011-08-18       Impact factor: 2.303

6.  Vaccine protection against simian immunodeficiency virus in monkeys using recombinant gamma-2 herpesvirus.

Authors:  John P Bilello; Julieta M Manrique; Young C Shin; William Lauer; Wenjun Li; Jeffrey D Lifson; Keith G Mansfield; R Paul Johnson; Ronald C Desrosiers
Journal:  J Virol       Date:  2011-09-07       Impact factor: 5.103

7.  The identification of HLA class II-restricted T cell epitopes to vaccinia virus membrane proteins.

Authors:  Richard B Kennedy; Gregory A Poland
Journal:  Virology       Date:  2010-10-18       Impact factor: 3.616

Review 8.  Definition of epitopes and antigens recognized by vaccinia specific immune responses: their conservation in variola virus sequences, and use as a model system to study complex pathogens.

Authors:  Alessandro Sette; Howard Grey; Carla Oseroff; Bjoern Peters; Magdalini Moutaftsi; Shane Crotty; Erika Assarsson; Jay Greenbaum; Yohan Kim; Ravi Kolla; David Tscharke; David Koelle; R Paul Johnson; Janice Blum; Steven Head; John Sidney
Journal:  Vaccine       Date:  2009-12-30       Impact factor: 3.641

9.  Safety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial.

Authors:  Stephen R Walsh; Marissa B Wilck; David J Dominguez; Elise Zablowsky; Shringkhala Bajimaya; Lisa S Gagne; Kelly A Verrill; Jane A Kleinjan; Alka Patel; Ying Zhang; Heather Hill; Aruna Acharyya; David C Fisher; Joseph H Antin; Michael S Seaman; Raphael Dolin; Lindsey R Baden
Journal:  J Infect Dis       Date:  2013-03-12       Impact factor: 5.226

Review 10.  Reverse vaccinology: developing vaccines in the era of genomics.

Authors:  Alessandro Sette; Rino Rappuoli
Journal:  Immunity       Date:  2010-10-29       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.